bf/NASDAQ:LPTX_icon.jpeg

NASDAQ:LPTX

Leap Therapeutics, Inc.

  • Stock

0.42

−0.69%

0.13

USD last updated 19/08 02:06:19

Last Close

0.29

18/08 22:28

Market Cap

75.00M

Beta: 0.74

Volume Today

217.02K

Avg: 600.93K

PE Ratio

−1.13

PFCF: −1.85

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -6-4-222019-04-012020-05-142022-03-112023-08-142024-08-12

    Revenue (Estimate*)

    200K400K600K800K1M1.20M2019-04-012020-05-142022-03-112023-08-142024-08-12

    *Estimate based on analyst consensus